Cancer Diagnosis and Prognosis After Guillain-Barré Syndrome: A Population-Based Cohort Study.

Blean Girma Dóra Körmendiné Farkas Kristina Laugesen Nils Skajaa Victor W Henderson Paolo Boffetta Henrik Toft Sorensen

Published in: Clinical epidemiology (2022)

GBS patients had a three-fold increased risk of cancer diagnosis in the first year of follow-up. The absolute cancer risk was almost 3.0%. A GBS diagnosis was an adverse prognostic marker for survival following cancer diagnosis. Clinicians should consider occult cancer in patients hospitalized with GBS.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
lymph node metastasis
squamous cell carcinoma
palliative care
childhood cancer
young adults
patient reported outcomes
case report
adverse drug